257 related articles for article (PubMed ID: 20162866)
1. Genetic testing offered directly after the diagnosis of colorectal cancer: a pilot study on the reactions of patients.
Landsbergen KM; Prins JB; Brunner HG; Hoogerbrugge N
Genet Couns; 2009; 20(4):317-25. PubMed ID: 20162866
[TBL] [Abstract][Full Text] [Related]
2. Knowledge and attitudes about microsatellite instability testing among high-risk individuals diagnosed with colorectal cancer.
Manne SL; Chung DC; Weinberg DS; Vig HS; Catts Z; Cabral MK; Shannon K; Meropol NJ
Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):2110-7. PubMed ID: 17932359
[TBL] [Abstract][Full Text] [Related]
3. [More hereditary intestinal cancer can be detected if patients with colorectal carcinoma that are selected by the pathologist are examined for microsatellite instability].
de Bruin JH; Kievit W; Ligtenberg MJ; Nagengast FM; Adang EM; Ruers TJ; Kleibeuker JH; Sijmons RH; van Krieken JH; Hoogerbrugge N
Ned Tijdschr Geneeskd; 2005 Aug; 149(32):1792-8. PubMed ID: 16121665
[TBL] [Abstract][Full Text] [Related]
4. Underutilization of microsatellite instability analysis in colorectal cancer patients at high risk for Lynch syndrome.
Van Lier MG; De Wilt JH; Wagemakers JJ; Dinjens WN; Damhuis RA; Wagner A; Kuipers EJ; Van Leerdam ME
Scand J Gastroenterol; 2009; 44(5):600-4. PubMed ID: 19153873
[TBL] [Abstract][Full Text] [Related]
5. Is it acceptable to approach colorectal cancer patients at diagnosis to discuss genetic testing? A pilot study.
Porteous M; Dunckley M; Appleton S; Catt S; Dunlop M; Campbell H; Cull A
Br J Cancer; 2003 Oct; 89(8):1400-2. PubMed ID: 14562005
[TBL] [Abstract][Full Text] [Related]
6. Challenges in the diagnosis and management of Lynch Syndrome in an Indigenous family living in a remote West Australian community.
Schofield L; Goldblatt J; Iacopetta B
Rural Remote Health; 2011; 11(4):1836. PubMed ID: 22188021
[TBL] [Abstract][Full Text] [Related]
7. Scoping the family history: assessment of Lynch syndrome (hereditary nonpolyposis colorectal cancer) in primary care settings--a primer for nurse practitioners.
Maradiegue A; Jasperson K; Edwards QT; Lowstuter K; Weitzel J
J Am Acad Nurse Pract; 2008 Feb; 20(2):76-84. PubMed ID: 18271762
[TBL] [Abstract][Full Text] [Related]
8. Lynch syndrome screening in newly diagnosed colorectal cancer in general pathology practice: from the revised Bethesda guidelines to a universal approach.
Morrison J; Bronner M; Leach BH; Downs-Kelly E; Goldblum JR; Liu X
Scand J Gastroenterol; 2011 Nov; 46(11):1340-8. PubMed ID: 21879804
[TBL] [Abstract][Full Text] [Related]
9. Who should be sent for genetic testing in hereditary colorectal cancer syndromes?
Lynch HT; Boland CR; Rodriguez-Bigas MA; Amos C; Lynch JF; Lynch PM
J Clin Oncol; 2007 Aug; 25(23):3534-42. PubMed ID: 17687158
[TBL] [Abstract][Full Text] [Related]
10. Intention to learn results of genetic testing for hereditary colon cancer.
Vernon SW; Gritz ER; Peterson SK; Perz CA; Marani S; Amos CI; Baile WF
Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 2):353-60. PubMed ID: 10207640
[TBL] [Abstract][Full Text] [Related]
11. Identification in daily practice of patients with Lynch syndrome (hereditary nonpolyposis colorectal cancer): revised Bethesda guidelines-based approach versus molecular screening.
Julié C; Trésallet C; Brouquet A; Vallot C; Zimmermann U; Mitry E; Radvanyi F; Rouleau E; Lidereau R; Coulet F; Olschwang S; Frébourg T; Rougier P; Nordlinger B; Laurent-Puig P; Penna C; Boileau C; Franc B; Muti C; Hofmann-Radvanyi H
Am J Gastroenterol; 2008 Nov; 103(11):2825-35; quiz 2836. PubMed ID: 18759827
[TBL] [Abstract][Full Text] [Related]
12. [Tumour examination to detect hereditary colorectal cancer].
Hoogerbrugge N; Hermens RP; Nagengast F; Overbeek L; van Krieken HJ; Ligtenberg M
Ned Tijdschr Geneeskd; 2012; 156(42):A4982. PubMed ID: 23075775
[TBL] [Abstract][Full Text] [Related]
13. Cancer patients who experienced diagnostic genetic testing for cancer susceptibility: reactions and behavior after the disclosure of a positive test result.
Bonadona V; Saltel P; Desseigne F; Mignotte H; Saurin JC; Wang Q; Sinilnikova O; Giraud S; Freyer G; Plauchu H; Puisieux A; Lasset C
Cancer Epidemiol Biomarkers Prev; 2002 Jan; 11(1):97-104. PubMed ID: 11815406
[TBL] [Abstract][Full Text] [Related]
14. Review article: The Lynch syndrome (hereditary nonpolyposis colorectal cancer).
Vasen HF
Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():113-26. PubMed ID: 18081655
[TBL] [Abstract][Full Text] [Related]
15. [Recognition of congenital endometrial carcinoma: the importance of family history and investigation of microsatellite instability in the tumour].
Hoogerbrugge N; Overbeek LI; de Hullu J; Kets CM; Hebeda KM; Ligtenberg MJ
Ned Tijdschr Geneeskd; 2007 Jun; 151(26):1441-4. PubMed ID: 17633970
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic and pedigree differences in amsterdam I-positive hereditary nonpolyposis colorectal cancer families according to tumor microsatellite instability status.
Valle L; Perea J; Carbonell P; Fernandez V; Dotor AM; Benitez J; Urioste M
J Clin Oncol; 2007 Mar; 25(7):781-6. PubMed ID: 17228022
[TBL] [Abstract][Full Text] [Related]
17. Prospective assessment of microsatellite instability in gastrointestinal neoplasia in Ashkenazi and non-Ashkenazi Jews.
Strul H; Liberman E; Kariv R; Gartner M; Kazanov D; Keidar A; Carmeli Y; Degani Y; Halpern Z; Arber N
J Med; 2003; 34(1-6):139-48. PubMed ID: 17682319
[TBL] [Abstract][Full Text] [Related]
18. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
[TBL] [Abstract][Full Text] [Related]
19. Review article: Detection and management of hereditary non-polyposis colorectal cancer (Lynch syndrome).
Ramsoekh D; Van Leerdam ME; Wagner A; Kuipers EJ
Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():101-11. PubMed ID: 18081654
[TBL] [Abstract][Full Text] [Related]
20. Comparison of individuals opting for BRCA1/2 or HNPCC genetic susceptibility testing with regard to coping, illness perceptions, illness experiences, family system characteristics and hereditary cancer distress.
van Oostrom I; Meijers-Heijboer H; Duivenvoorden HJ; Bröcker-Vriends AH; van Asperen CJ; Sijmons RH; Seynaeve C; Van Gool AR; Klijn JG; Tibben A
Patient Educ Couns; 2007 Jan; 65(1):58-68. PubMed ID: 16872788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
